Clinical Trials Logo

Vaginitis clinical trials

View clinical trials related to Vaginitis.

Filter by:

NCT ID: NCT01867164 Completed - Vaginitis Clinical Trials

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The purpose of this comparative study is to evaluate the efficacy of an ovule with triple active agents (terconazole, clindamycin and fluocinolone) versus another ovule with triple active agents (nystatin, metronidazole and fluocinolone) in the treatment of symptoms caused by the presence of vaginitis (inflammation of the vagina) or bacterial vaginosis (polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli).

NCT ID: NCT01832480 Completed - Clinical trials for Vaginitis Trichomonal or Due to Trichomonas

Trichomonas Vaginalis Repeat Infections Among HIV Negative Women

Start date: October 6, 2014
Phase: Phase 3
Study type: Interventional

The overall goal of this project is to determine the influence of patient treatment and host factors on repeat Trichomonas vaginalis (TV) infections among HIV-negative women

NCT ID: NCT01593124 Completed - Vaginal Infections Clinical Trials

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

Biomarkers
Start date: May 2012
Phase: Phase 2
Study type: Interventional

This study investigates the response of vaginal and cervical tissue after exposure to three vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ) cream.

NCT ID: NCT01507454 Completed - Menopause Clinical Trials

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

Start date: April 2006
Phase: N/A
Study type: Observational

This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.

NCT ID: NCT01486979 Completed - Menopause Clinical Trials

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

Start date: January 2007
Phase: Phase 1
Study type: Interventional

This trial is conducted in Europe. The aim of this trial is to to evaluate the extent of systemic absorption of estradiol during treatment with two different doses of estradiol in postmenopausal women with atrophic vaginitis.

NCT ID: NCT01436513 Completed - Menopause Clinical Trials

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Start date: October 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the bioequivalence and food effect for a new Premarin formulation compared with a Premarin reference tablet in Japanese healthy postmenopausal women.

NCT ID: NCT01370551 Completed - Atrophic Vaginitis Clinical Trials

Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

Gynoflor
Start date: April 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the longterm safety and efficacy of the vaginal application of Gynoflor®, an extremely low dosed estrogen therapy with lactobacilli, on atrophic vaginitis in postmenopausal breast cancer patients who have been treated with aromatase inhibitors.

NCT ID: NCT01361048 Completed - Clinical trials for Trichomonas Vaginitis

Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis

Start date: December 2011
Phase: Phase 2
Study type: Interventional

The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.

NCT ID: NCT01335373 Completed - Bacterial Vaginosis Clinical Trials

Observational Program Neo-Penotran® Forte

Start date: October 2010
Phase: N/A
Study type: Observational

Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis or mixed infection. Neo-Penotran Forte is registered for treatment of these most common vaginal infections. Efficacy and safety of this product is already established, and this observational study was designed to learn more about practical use of Neo-Penotran® Forte in real life setting.

NCT ID: NCT01050465 Completed - Obesity Clinical Trials

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Start date: May 2009
Phase: N/A
Study type: Interventional

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.